During the past decade, Molecular Pathology Laboratory Network, Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Molecular Pathology Laboratory Network, Inc" are "Chlamydia Infections" (1 trials), "Gonorrhea" (1 trials) and "Human Papillomavirus Infection" (1 trials). Many other conditions were trialed in "Molecular Pathology Laboratory Network, Inc" in a lesser frequency.

Most popular intervention types in "Molecular Pathology Laboratory Network, Inc" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "APTIMA Assays; PANTHER System" (1 trials) and "APTIMA HPV Assay" (1 trials). Other intervention names were less common.

The vast majority of trials in "Molecular Pathology Laboratory Network, Inc" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Molecular Pathology Laboratory Network, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Molecular Pathology Laboratory Network, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Molecular Pathology Laboratory Network, Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".